U.S. markets close at red notes on Monday    European markets advance on Tuesday    EFG Hermes Holding, GB Capital launch Kaf    Egypt ready to build up international centre for storage, supply and trade grains – minister    Liz Truss to relax immigration rules to boost UK economy    Egypt launches automated vaccine cold storage at VACSERA    Apple to hike App Store prices in Egypt and other countries in Asia, Europe    Dior new pre-fall men collection to take place for the first time in Egypt    Kazakhstan's President awards Egypt's Azhar imam Astana International Prize    Three possible scenarios as Egypt's central bank governor resigns – MP    Adele is living a love story, wants to be a homemaker    In Photos: Egypt swears in 13 new ministers after major Cabinet reshuffle    Egypt's Sisi names 13 ministers in Cabinet reshuffle    Spain: prosecutor seeks 8 years sentence for Shakira over tax evasion    Egypt: Alamein Art Festival kicks off a collection of recycled installations    John Legend enjoys family trip in Egypt    Egypt's athlete Basma Emad wins bronze in weightlifting in Mediterranean Games    Noura Al-Mutair – first Gulf female boxer in World Championships    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Mayo Clinic researchers pinpoint genetic variations that might sway course of COVID-19
Published in Amwal Al Ghad on 11 - 08 - 2022

Researchers at U.S. non-profit organisation Mayo Clinic announced on Thursday that they discovered key human genomic signatures that could help explain why COVID-19 is severe in some people and mild in others.
After analysing volumes of diverse worldwide DNA sequence data, the scientists identified mutations in two human proteins that might sway the course of SARS-CoV-2, the virus responsible for COVID-19.
Their study reveals that variants in the genes for ACE2 and TMPRESS2 can lead to an increase or decrease in protein expression. An increase in protein expression might result in elevated COVID-19 susceptibility and severity, while a decrease might have a protective effect against the virus. Proteins play many critical roles in the body. In this case, ACE2 and TMPRESS2 provide critical entry points for SARS-CoV-2 to invade and infect human cells.
The study findings, published in Human Molecular Genetics, is suggesting a potential new diagnostic approach that is based on variation in the host cells rather than the constantly evolving virus itself.
"COVID-19 is a master of frequency in changing the sequences of its genes, but that only tells half of the story." said Lingxin Zhang, the lead author of the study and a researcher in the Pharmacogenomics Programme of the Centre for Individualised Medicine.
"Our findings suggest that the virus's interaction with proteins encoded by the human genome may also be a contributor to a person's disease outcome," Zhang added.
"These results can now be applied to DNA sequence data for patients infected with SARS-CoV-2 to potentially determine the degree of susceptibility to the disease,"
"I hope this methodology can be expanded for other genes involved in COVID-19, and that scientists and clinicians across the world can use this information to help their patients."
For the study, Zhang and her team delved deep into the DNA sequencing data of nearly 71,000 people worldwide, including nearly 30,000 racial and ethnic minorities, to identify sequence variants in the ACE2 and TMPRESS2 genes.
The team then analysed hundreds of protein variants encoded by those genes and identified variant genes that generated high and low expression levels. To do that, Zhang engineered cells capable of expressing the protein variants, and then, using color-coding, she and her team analysed the variants to see which were more or less stable.
The study used nearly a million generated cells and produced billions of data points, which the team analyzed using a series of technologies, including cell sorting, modern genomics, high throughput DNA sequencing and a computer algorithm.
"To our knowledge, it's the first time anyone has applied this approach to COVID-19," said Richard Weinshilboum, M.D., co-author of the study and a pharmacologist in the Centre for Individualised Medicine, and Department of Molecular Pharmacology and Experimental Therapeutics.
"This work would not have been possible without the dramatic advances that have occurred in DNA sequencing, joined together with parallel advances in our ability to test the functional and medical implications of individual variations in DNA sequence — and, as a result — of individual variation in the proteins encoded by our genes."
Weinshilboum said the study also was made possible by the large quantity of human DNA sequence information that is now publically available — with the proviso that those data must be carefully protected and must have their use reviewed and approved to avoid any possible violation of privacy.
As of July 11, 2022, more than 6.3 million people worldwide have died from COVID-19 since the start of the pandemic.
This study was funded by NIH grants U19 GM61388 (The Pharmacogenomics Research Network), R01 GM028157, R01 GM125633, R01 AA027486, K01 AA28050 and by the Mayo Clinic Centre for Individualised Medicine.

Clic here to read the story from its source.